Neurobo Pharmaceuticals - Delisted Stock
Neurobo Pharmaceuticals is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Neurobo Pharmaceuticals was actively traded. Please check the stock traded under the symbol MTVA.
Neurobo Pharmaceuticals Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Neurobo Pharmaceuticals market risk premium is the additional return an investor will receive from holding Neurobo Pharmaceuticals long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.50) | |||
| Total Risk Alpha | (1.28) | |||
| Treynor Ratio | (2.54) |
| The entity Neurobo Pharmaceuticals with a symbol NRBO was recently relisted or delisted. You can potentially use MTVA New with a symbol MTVA. Please make sure the ticker renaming or change in the classification of Neurobo Pharmaceuticals is not a temporary action by the exchange. |
Neurobo Pharmaceuticals Corporate Management
| PharmD BCPS | VP Operations | Profile | |
| Robert Homolka | Senior Operations | Profile | |
| Ben MD | CEO Pres | Profile | |
| Frank Kondrad | VP Devel | Profile | |
| MiKyung Kim | Chief Officer | Profile |
Still Interested in Neurobo Pharmaceuticals?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurobo Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Neurobo Stock
If you are still planning to invest in Neurobo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neurobo Pharmaceuticals' history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |